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Negative pressure wound therapy on exposed
prosthetic vascular grafts in the groin
Paul Berger, MD, Dennis de Bie, MaNP, Frans L. Moll, MD, PhD, and
Gert-Jan de Borst, MD, PhD, Utrecht, The Netherlands
Objective: This study assessed the outcome of vacuum-assisted closure (VAC) as primary therapy for exposed prosthetic
vascular grafts in the groin (Szilagyi III).
Methods: The study included all consecutive patients with Szilagyi III groin infections and exposed prosthetic graft
material from 2009 to 2011. After initial wound debridement, VAC was applied using a two-layer combination,
consisting of polyvinyl alcohol and polyurethane sponges. Continuous negative pressure was set on a maximum of 50mm
Hg. All patients received complementary antibiotic therapy. The primary end point was defined as complete wound
closure. Secondary end points comprised bleeding complications, amputation, and death.
Results: The study evaluated 15 patients with 17 Szilagyi III groin infections. Mean total length of VAC therapy was 43
days (range, 14-76 days). Mean time until complete healing was 51 days (range, 24-82 days). Mean length of VAC
therapy in the hospital was 21 days (range, 5-61 days). Eleven patients received continued VAC treatment at home for a
mean length of 22 days (range, 5-69 days). Complete healing was achieved in 14 groins (82%). Three failures due to
persisting infection, persisting necrosis, and a pseudomonas infection were noted. No bleeding complications, amputa-
tions, or late reinfections occurred. Median follow-up was 380 days (range, 56-939 days). Despite therapy failure, all 17
grafts were preserved.
Conclusions: VAC therapy on an exposed prosthetic vascular graft in the groin is safe and feasible when applying a
combination of polyvinyl alcohol and polyurethane foam dressing and 50 mm Hg of continuous negative pressure,
resulting in midterm graft preservation. (J Vasc Surg 2012;56:714-20.)
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wA wound infection in the groin is a common complica-
tion after vascular bypass surgery. Risk factors for groin
infection include diabetes, obesity, immune-compromised
status, and redo surgery. Groin infections limited to the
skin or subcutis usually are treated by debridement, with or
without adjunctive antibiotics. Deep groin infections pose a
different problem, especially when the prosthetic material
used for arterial reconstruction is exposed. In these situa-
tions, most local treatment options tend to fail, and re-
moval of the graft with alternative restoration of limb
perfusion may be the only option to achieve wound healing
without major tissue loss in the lower extremity. Most
patients with graft infections, however, have significant
comorbidities and will not be able to withstand this type of
major reconstructive surgery.
Associated morbidity and amputation rates are high1-4
and have prompted the search for alternative techniques to
preserve the graft and thereby limit the operative trauma.
Most of these include (extensive) debridement and muscle
flap coverage, combined with high-dose and often lifelong
use of antibiotics. Muscle flap coverage, however, is no
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714uarantee for successful wound healing and has reported
ailure rates up to 35%.5,6
A completely different approach uses the application of
he vacuum-assisted closure (VAC) system (KCI Medical,
an Antonio, Tex), with or without additional muscle flap
orrection. This treatment strategy has been studied in
roin wound closure but mostly without underlying pros-
hetic bypass material involvement. To our knowledge,
nly four case studies have described the use of VAC as the
rimary treatment for groin wound closure after previous
rterial prosthetic reconstructive surgery.7-10 The present
eport describes our preliminary experience using a double-
ponge VAC technique in groin infections with exposed
rosthetic grafts, along with short-term clinical follow-up
esults. The double-sponge technique has never been re-
orted before for the treatment of exposed and infected
ypass grafts.
ETHODS
All consecutive patients presenting with a deep groin
nfection and exposed vascular graft in our institution be-
ween 2009 and 2011 were included in this study. Groin
nfections were graded according to depth of involvement
Szilagyi classification),11 defined as grade I, infection lim-
ted to the dermis; grade II, infection limited to the subcu-
aneous space without graft involvement; and grade III,
nfection with vascular graft involvement. All patients with
Szilagyi III groin infection were included. All wounds
ere open groin defects of at least 2-cm width, combined
ith a fully exposed vascular graft. The study excluded
atients with a groin infection without graft involvement
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Volume 56, Number 3 Berger et al 715(Szilagyi I and II), with venous grafts, or with noninfected
seroma or hematoma.
Baseline blood cultures were obtained along with indi-
cators of standard infection and renal function. In all pa-
tients, initial antibiotic therapy was started using Amx-
clavulanate as the primary broad-spectrum antibiotic
according to hospital protocol. As soon as cultures were
known, the antibiotics were adjusted if necessary. Patient
demographics were scored according to the Society for
Vascular Surgery (SVS) guidelines.12 Initial intervention,
time to VAC placement, total hospital length of stay, total
VAC treatment time, time to complete healing, and total
follow-up time were recorded.
The primary end point was defined as complete wound
closure. Secondary end points were comprised of bleeding
complications, amputation, and death.
SURGICAL PROCEDURE
All included patients were primarily treated with a
VAC system while they were under general anesthesia.
Extensive debridement was performed and all infectious
and necrotic tissue was removed. Cultures were taken
from any available pus, and swab cultures were taken
from the graft itself and from the surrounding tissue
(Table I). The vascular anastomosis was checked for
integrity, and if so, a VAC system was applied immedi-
ately and directly on the prosthesis. In case of sepsis, the
initial procedure was limited to abscess drainage and the
wound was thoroughly rinsed twice a day. VAC applica-
tion was done after clinical stabilization.
In all patients, a double-sponge technique was used
to apply the VAC. First, a white polyvinyl-alcohol (PVA)
foam sponge (WhiteFoam, KCI Medical, San Antonio,
Tex) was applied to cover the graft completely. This is a
hydrophilic, nonadherent sponge with a pore size of
0.06 to 0.27 mm. On top of this white sponge, black
polyurethane foam sponges (GranuFoam; KCI Medical)
were used to cover the wound completely (Fig 1).
GranuFoam is a hydrophobic sponge with an open-pore
structure with a pore size of 0.4 to 0.6 mm. Additional
sartorius plasty was used in selected cases to cover part of
the wound, thereby limiting wound size. At the end of
Table I. Microbiology of initial cultures
Microorganism No. (%)
Methicillin-sensitive Staphylococcus aureus 6 (40)
Streptococcus 4 (27)
Escherichia coli 2 (13)
Enterococcus 1 (7)
Coagulase-negative Staphylococcus 1 (7)
Pseudomonas aeruginosa 1 (7)
Staphylococcus spp 1 (7)
Acinetobacter 1 (7)
Candida albicans 1 (7)
Mixed flora 7 (47)
Negative culture 3 (20)the operation, the VAC pump was set on a maximum wontinuous topical negative pressure of 50 mm Hg,
hich was used for the duration of the treatment. The
AC procedure was the primary procedure for all pa-
ients, meaning no preceding or additional graft removal
as performed.
Wound inspections and sponge changes were done
referably every 3 days on the ward. Large wounds and the
eed for complementary debridement were indications for
ound inspection at the operating theater with the patient
nder general anesthesia. In every consecutive procedure,
maller sponges were applied to ensure reduction of the
nfectious cavity. All patients received culture-guided anti-
iotics for at least 6 months. Because there is no evidence in
he literature on the length of postoperative antibiotic
herapy, the duration was based on intention to treat.
atients were hospitalized at least until granulation tissue
tarted to show on the graft. VAC therapy was continued (if
ecessary at home) until complete wound closure (primary
nd point) was established. Outpatient follow-up was done
nce every week. Our treatment protocol is shown in Fig 2.
ESULTS
Patient characteristics. A total of 15 patients (10
en) with 17 groin infections were included.Mean age was
9 years (range, 51-88 years). Almost half of the patients
ere current smokers, and seven of 15 (47%) were previous
mokers. Diabetes was present in four of 15 of the patients
27%). Most patients had hypertension, with eight of 15
53%) using more than one drug to control the blood
ressure. Cardiac status was relatively mild, with only one
atient at SVS class 2 and one patient at SVS class 3. Five
atients had SVS pulmonary status class 2 and 3. Serum
reatinine levels exceeded 2.5 mg/dL in three patients.
atient characteristics and medical history are summarized
n Table II.
The initial operative procedures in our institution were
ll for vascular indications, varying from abdominal aortic
neurysms to a traumatic external iliac lesion. Most patients
nderwent a bypass graft, and one patient had a femoral
ndarterectomy and synthetic (Dacron) patch plasty. In 11
atients, a Dacron graft was used; in nine patients polytet-
afluoroethylene. Details on the initial operations and indi-
ations are reported in Table III.
Microbiology. Six patients presented with frank pus
n the groin wound. Cultures taken during the initial
peration were negative in three patients (20%). All were
reviously treated with antibiotics due to a vascular graft
nfection. Most of the isolated microorganisms were
taphylococci spp, and in 47% of the patients, more than one
icroorganism was found in the initial culture. Microbiol-
gy results are reported in Table I.
Treatment outcome. The 17 groins were followed-
p over a median of 380 days (range, 56-939 days).
ean total length of VAC therapy was 43 days (range,
4-76 days). In 12 groins, the VAC was changed in the
perating theater, with a median of two procedures (range,
-14 times). Complete wound closure (primary end point)
as achieved in 14 groins (82%), with a mean time until
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September 2012716 Berger et alcomplete healing of 51 days (range, 24-82 days). Median
length of VAC therapy in the hospital was 17 days (range,
5-61 days). Another 11 groins were further treated using
VAC at home for a mean length of 22 days (range, 5-69
days). Fig 3 shows an example of a successful treatment.
Two groins were completely healed during the hospital
stay. In three patients, a transposition of the sartorius
muscle was used during the initial operation to decrease
the depth of the wound. We observed no bleeding
complications, amputations, late groin reinfections, or
death during follow-up (secondary end points). For
further details, see Table IV.
VAC therapy failed in three groins of three different
patients. The first patient was an 87-year-old fragile woman
with an infected Dacron graft femorofemoral bypass. Both
groins were treated with VAC. Initial results were promis-
ing, and granulation tissue was found in both groins. Her
progress was monitored in the outpatient clinic. Although
the left groin showed adequate improvement and wound
healing, the right did not. After 47 days, the VAC therapy
was stopped. Because her clinical condition did not allow
for any other therapy, we decided to accept this nonoptimal
situation. With a follow-up of 446 days, the prosthesis is
still exposed in the left groin with the right groin com-
pletely healed. She is doing relatively well in a nursing
home. In-depth analysis of the case did not yield any
detrimental factors of the failed groin (both groins were
comparably infected and both showed the same microor-
ganism in the cultures). We therefore have no clear expla-
nation for this difference in healing.
In the second patient, healing also ceased after an initial
good effect. Cultures showed Pseudomonas, and the VAC
therapy was stopped. She was treated with acetic acid, and
the groin was healed completely after 7 weeks.
The last patient also showed initial good effect of the
VAC, but because of persisting necrosis, an extensive de-
bridement was planned. A rectus femoris muscle flap was
used to cover the wound and prosthesis. VACwas reapplied
and successfully used to heal the wound.
In two of these patients, a Dacron graft was used as
Fig 1. Vacuum-assisted closure (Vprosthetic material. In one patient, polytetrafluoroethylene vas used. No significant correlation between graft material
nd infection could be shown.
ISCUSSION
This is the first report on the double-sponge technique
s primary treatment for wound infections with underlying
rosthetic vascular grafts. A combination between White-
oam and GranuFoam sponges was used with a gentle
ontinuous negative pressure of 50 mmHg combined with
ntibiotic therapy. This treatment strategy achieved graft
reservation up to a 31-month follow-up.
Graft infections pose a challenging problem in vas-
ular surgery. Traditionally, graft infections are treated
y extensive debridement and removal of all infected
issue, including the graft, followed by some kind of
evascularization. These procedures are major interven-
ions and are associated with serious morbidity and
ortality rates. Groin infections after vascular surgery
ave an incidence of up to 5%11,13 and pose a specific
roblem because reconstruction options are very limited.
atients with a graft infection are often critically ill, and
ost will not be able to withstand a major operation.
hese are the main reasons attempts have been made to
reserve the graft in the groin.
One of the most accepted options is muscle flap cover-
ge. Although this procedure can be quite effective, with
uccess rates of up to 75%,7,14,15 reinfection rates of up to
5% have been reported.5,14,16 Muscle flap coverage thus
an be a time-consuming procedure that can have detri-
ental effects on the already poor overall condition of the
atient. Additional sartorius muscle transposition was used
n three patients in our series, mainly to cover part of the
ound, thereby limiting the cavity needing to be filled with
AC sponges.
The clinical guidelines for use of VAC explicitly
ame exposed blood vessels and anastomotic sites a
ontraindication for the use of VAC.17 An important
onsideration in this contraindication is the risk for
nastomotic disruption and possible fatal bleeding. KCI
edical recommends completely covering the exposed
herapy, double-sponge technique.essels with a thick layer of natural tissue, multiple layers
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Volume 56, Number 3 Berger et al 717of fine-meshed nonadherent material, or bioengineered
tissue as protective material to avoid direct contact of the
sponges with the vessels.
Only four reports on case series of Szilagyi IIIwithVACas
a definitive treatment have been published so far.7-10 The
largest study, which included 24 patients with Szilagyi III,
used a modified VAC system with PVA sponges and a redon
drain and applied a continuous vacuumpressure of 400 to600
mmHg.9 The spongeswere applied adjacent (but not directly
on) to the anastomoses for 14 days, after which all wounds
were closed definitively by sutures. A 100% success rate was
SzilSzilagyi
Fig 2. Treatment strategy.reported. Svensson et al10 used VAC in 21 Szilagyi III groins with a 71% success rate. The third study is from Dosluoglu et
l,7 who used VAC in 12 Szilagyi III groins and reported an
3% success rate. Svensson et al10 and Dosluoglu et al7 used a
onadhesive dressing (Kendall/Curity [Tyco Healthcare,
ansfield, Mass] or Mepitel [Mölnlycke Health Care AB,
öteborg, Sweden]) to cover the graft before sponge appli-
ation. The last study is fromKotsis andLioupis,8 who treated
ix Szilagyi III groins. They placed the VAC directly on the
essel wall but not in contact with an exposed or uncovered
nastomotic line. All groups, except Pinocy et al,8 used a
ontinuous topical negative pressure of 125 mm Hg, which
Szilagyi
, Vacuum-assisted closure.agyias more than double the pressure used in our protocol.
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nonfatal anastomotic bleeding (respectively, two and one)
during VAC therapy. With the risk of bleeding complica-
tions in mind, we have adopted a different policy for VAC
in Szilagyi III groins with exposed graft material. First, we
apply the VAC sponges directly on the anastomosis, but
instead of using a nonadhesive drape, we cover the anasto-
mosis with white nonadherent PVA foam (WhiteFoam)
sponge with very small pores. The small pore structure
lessens the adhesive strength of the sponge, allowing it to
be applied on relatively delicate structures such as skin
transplants or vascular anastomoses. The direct application
of VAC on the prosthesis theoretically accelerates granula-
tion formation on the prosthesis (as shown in Fig 4). On
top of the WhiteFoam, we use the black GranuFoam
sponge to cover the wound completely.
Second, we use a continuous topical negative pressure
of 50 mm Hg instead of 125 mm Hg. We believe this
approach promotes periarterial granulation tissue forma-
Table II. Patient characteristics
Variable No. (%)
Smoking
Current 7 (47)
Within last 10 years 7 (47)
Diabetes
Insulin use 1 (7)
Noninsulin use 3 (20)
Hypertension
Controlled with 1 drug 3 (20)
Controlled with 1 drug 8 (53)
Cardiac status
SVS 2 1 (7)
SVS 3 1 (7)
Pulmonary status
SVS 2 4 (27)
SVS 3 1 (7)
Creatinine level, mg/dL
2.5-5.9 2 (13)
5.9 1 (7)
SVS, Society for Vascular Surgery.
Table III. Indication and initial operations in our
institution
Variable No. (%)
Indication for operation
Abdominal aortic aneurysm 5 (33)
Claudication 2 (13)
Rest pain 3 (20)
Tissue loss 2 (13)
Graft infection 3 (20)
Traumatic 1 (7)
Operation
Aortobifemoral 5 (33)
Iliofemoral 4 (27)
Femoropopliteal 4 (27)
Femorofemoral 3 (20)
Endarterectomy and synthetic patch 1 (7)tion and minimizes the risk of bleeding complications. vTable IV compares the different study outcomes, in-
luding our own. Very recently, a large retrospective series
as published concerning the long-term follow-up of VAC
irectly on native arteries or a vascular anastomosis in
atients with Szilagyi III. Continuous topical negative pres-
ure was started at 50 to 75mmHgbut was changed to 125
m Hg as soon as the acute inflammation had ceased.
owever, because of the heterogenicity of the graft loca-
ion (varying from the carotid artery to the lower leg), its
esults cannot be directly extrapolated to our population.18
VAC treatment is a time-consuming therapy and can
herefore be demanding for the patient. One might argue
hat our use of the WhiteFoam sponge and lower topical
ressure lengthens treatment time. Our mean treatment
ime was 43 days, which is relatively long compared with
he other studies. However, time to complete healing was
1 days, which compares positively with the other studies.
urthermore, none of our patients experienced any bleed-
ng complications when we placed the VAC directly on the
nastomosis, without any protective layer.
To limit hospital length of stay, we make an effort to
ischarge patients as soon as their clinical condition allows.
AC is continued at home for as long as needed, and the
ystem is changed every 3 days by a specialist nurse team
hat is also on-call for any equipment problems. We see the
atient every week in our outpatient clinic to check on the
rogress. Most patients can cope with this strategy very
ell.
In every strategy to preserve a vascular graft, the viru-
ence of the microorganism causing the infection is seen as
major factor for failure or success.19 Pseudomonas is a
ighly virulent microorganism that does not respond very
ell to conservative therapy, including antibiotics. This is
ne of the reasons most studies of vascular graft infections
ecommend graft removal if Pseudomonas is present. In-
eed, in both failures in the series of Dosluoglu et al,7
seudomonas was cultured. The first failure was caused by
leeding, which prompted emergency graft removal, and
he second failure was caused by a late reinfection leading to
artial graft removal and a bypass. Kotsis and Lioupis8 also
reated one patient who had Pseudomonas infection, with
o modifications of the VAC therapy but with good result:
fter 45 VAC days, the wound was almost completely
ranulated. In our series, two patients presented with Pseu-
omonas infection. We stopped the VAC treatment in the
rst patient and switched to acetic acid gauzes with good
esults. The second patient, however, had a very large
ound in his left groin and we were reluctant to stop the
AC treatment. To assist in the eradication, we rinsed the
AC system every day with acetic acid and therapy was
ontinued as in the other patients. The groin healed after
6 days.
We have shown that good clinical short-term results
an be achieved using this protocol. Even though an
nfection may seem limited to the groin, it is absolutely
nclear whether the rest of the bypass remains free of
nfection. VAC offers a minimally invasive graft preser-
ation option that can also be used to treat failing
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Volume 56, Number 3 Berger et al 719conservative graft infection treatment (in three of our
patients). Vascular graft removal is the gold standard to
eradicate vascular graft infections. Our strategy should be
seen as an alternative graft preservation technique for those
patients who will not be able to endure graft removal and
revascularization. Antibiotic treatment is an essential ad-
junct for successful graft preservation. It may not be able to
cure the infection, but it will suppress the infection to an
extent. It is unclear if VAC with assisted antibiotic treat-
Fig 3. Vacuum-assisted cl
Table IV. Results of VAC
Svensson et al10 Dosluoglu et
No. of patients with Szilagyi III 21 12
Duration VAC, d 20 (total group) 26
Hospital stay, d
Mean NS 20.5
Median (range)
Follow-up, mo
Mean (SD) 16 33.4 (19.5
Median (range)
Success rate, % 71 83
Bleeding complications, % 9.5 8
Recurrence, % 0 8
Mortality, % 33 0
Late infections, % 14 0
Amputation, % 18 8
NS, Not stated; VAC, vacuum-assisted closure.
aModified VAC system and secondary closure after 14 days.ment will be able to eradicate the infection completely. aven though none of our patients has experienced any late
nfectious complications, our follow-up is limited. Long-
erm results, which are not yet available, are needed to
onfirm whether the outcome of VAC combined with
ntibiotics will remain successful.
ONCLUSIONS
VAC is a valuable tool for graft preservation in infected
roins. Despite gut feeling and the instructions for use,
(VAC) treatment success.
Kotsis & Lioupis8 Pinocy et al9a Berger et al (current study)
6 24 17
21.5 (total group) 14 43
37.4 NS
17 (5-61)
16 12
13 (2-31)
100 100 82
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0al7
)pplication of VAC directly on exposed grafts can be safe.
11
1
1
1
1
1
1
1
1
tissue
JOURNAL OF VASCULAR SURGERY
September 2012720 Berger et alTo avoid complications, we advocate a combination of
WhiteFoam and GranuFoam sponges and a topical nega-
tive pressure of 50 mm Hg.
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